Morphometric demonstration of atrophic changes in the ceRebral cortex, white matter, and neostriatum in huntington’s disease

Journal of Neuropathology and Experimental Neurology

Volumn 47, Issue 5, 1988, Pages 516-525

  De La Monte, Suzanne M ^a   Vonsattel, Jean Paul ^a   Richardson, E P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atrophy; Cerebral; Dementia; Huntington s disease; Hydrocephalus; Morphometry

Indexed keywords

ADULT; AGED; AUTOPSY; BRAIN ATROPHY; BRAIN CORTEX; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DEMENTIA; FATALITY; FEMALE; HISTOLOGY; HUMAN; HUNTINGTON CHOREA; HYDROCEPHALUS; MALE; MORPHOMETRICS; NEOSTRIATUM; PRIORITY JOURNAL; WHITE MATTER;

ADULT; AGED; ATROPHY; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; FEMALE; HUMAN; HUNTINGTON DISEASE; HYDROCEPHALUS; MALE; MIDDLE AGE; ORGAN SPECIFICITY; REFERENCE VALUES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023750525     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-198809000-00003     Document Type: Article

References (38)

1. Hayden MR, Huntington’s chorea. Berlin: Springer-Verlag, 1981
2. Bruyn GW, Bots GTAM, Dom R. Huntington’s chorea: Current neuropathological status. In: Chase TN, Wexler NS, Barbeau A, eds. Huntington’s disease. Advances in neurology. Volume 23. New York: Raven Press, 1979:83-93
3. Earle KM. Pathology and experimental models of Huntington’s chorea. In: Barbeau A, Chase TN, Paulson GW, eds. Huntington’s chorea 1872-1972. Advances in neurology. Volume 1. New York: Raven Press, 1973:341-51
4. Lange HW. Quantitative changes of telencephalon, diencephalon, and mesencephalon in Huntington’s chorea, postencephalitic, and idiopathic parkinsonism. Verh Anat Ges 1983;75:923-5
5. Conneally PM. Huntington disease: Genetics and epidemiology. Am J Hum Genet 1984;36:506-26
6. Bugiani O, Tabaton M, Cammarata S. Huntington’s disease: Survival of large striatal neurons in the rigid variant. Ann Neurol 1984;15:154-6
7. Roos RAC, Pruyt JFM, de Vries J, Bots GTAM. Neuronal distribution in the putamen in Huntington’s disease. J Neurol Neurosurg Psychiatry 1985;48:422-5
8. Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 1985;44:559-77
9. Sluga-Gasser E. Zur ultrastruktur des striatums. Vorlaufige Ergebnisse einer cerebralen biopsie. Wien Z Nervenheilk 1966;23:17-35
10. Tellez-Nagel I, Johnson AB, Terry RD. Studies on brain biopsies of patients with Huntington’s chorea. J Neuropathol Exp Neurol 1974;33:308-32
11. Roizin L, Kaufman M A, Willson N, Stellar A, Liu JC. Neuropathologic observations in Huntington’s chorea. In: Zimmermann HM, ed. Progress in neuropathology. Volume 3. New York: Grune and Stratton, 1976:447-88
12. Fomo LS, Norville RL. Ultrastructure of the neostriatum in Huntington’s and Parkinson’s disease. In: Chase TN, Wexler NS, Barbeau A, eds. Huntington’s disease. Advances in neurology. Volume 23. 1977:123-35
13. Constantinidis J, Bouras C, Richard J. Putative peptide neurotransmitters in human neuropathology: A review of topography and clinical implications. Clin Neuropathol 1983;2:47-54
14. Kanazawa I, Sasaki H, Muramoto O, et al. Studies on neurotransmitter markers and striatal neuronal cell density in Huntington’s disease and dentatorubropalliodoluysian atrophy. J Neurol Sci 1985;70: 151-65
15. Grafe MR, Fomo LS, Eng LF. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington’s, Parkinson’s and Alzheimer’s diseases. J Neuropathol Exp Neurol 1985;44:47-59
16. Sagar SM, Beal MF, Marshall PE, Landis DM, Martin JB. Implications of neuropeptides in neurological diseases. Peptides (Fayetteville) 1984;5(Suppl l):255-62
17. Graveland GA, Williams RS, DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington’s disease. Science 1985;227:770-3
18. Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB. Selective sparing of a class of striatal neurons in Huntington’s disease. Science 1985;230:561-3
19. Beal MF, Bird ED, Langlais PJ, Martin JB. Somatostatin is increased in the nucleus accumbens in Huntington’s disease. Neurology 1984;34:663-6
20. Dawbam D, De Quidt ME, Emson PC. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington’s disease. Brain Res 1985;340:251-60
21. Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EP Jr. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington’s disease. J Neuropathol Exp Neurol 1987;46:12-27
22. Ferrante RJ, Beal MF, Kowall NW, Richardson EP Jr, Martin JB. Sparing of acetylcholinesterase-containing striatal neurons in Huntington’s diseases. Brain Res 1987;411:162-6
23. Sax DS, O’Donnell B, Butters N, Menzer L, Montgomery K, Kayne HL. Computed tomographic, neurologic, and neuropsychological correlates of Huntington’s disease. Int J Neurosci 1983; 18: 21-36
24. Stober T, Wussow W, Schimrigk K. Bicaudate diameter—The most specific and simple CT parameter in the diagnosis of Huntington’s disease. Neuroradiology 1984;26:25-8
25. Mayeux R, Stem Y, Rosen J, Benson DF. Is “subcortical dementia” a recognizable clinical entity? Ann Neurol 1983;14:278-83
26. Dunlap CB. Pathologic changes in Huntington’s chorea with special reference to the corpus striatum. Arch Neurol Psychiat 1927;18:867-943
27. Bull JWD. The Robert Wartenberg memorial lecture. The volume of the cerebral ventricles. Neurology 1961;11:1-9
28. Reid AC, Matheson MS, Teasdale G. Volume of the ventricles in benign intracranial hypertension. Lancet 1980;2:7-8
29. Condon BR, Patterson J, Wyper D, et al. A quantitative index of ventricular and extraventricular intracranial CSF volumes using MR imaging. J Comput Assist Tomogr 1986;10:784-92
30. Tanahashi N, Meyer JS, Ishikawa Y, et al. Cerebral blood flow and cognitive testing correlate in Huntington’s disease. Arch Neurol 1985;42:1169-75
31. Noth J, Engel L, Friedemann H-H, Lange HW. Evoked potentials in patients with Huntington’s disease and their offspring. I. Somatosensory evoked potentials. Electroencephalogr Clin Neurophysiol 1984;59:134-41
32. McCaughey WTE. The pathologic spectrum of Huntington’s chorea. J Nerv Ment Dis 1961; 133: 91-103
33. Myers RH, Sax DS, Schoenfeld M, et al. Late onset of Huntington’s disease. J Neurol Neurosurg Psychiatry 1985;48:530-4
34. Myers RH, Vonsattel JP, Stevens TJ, et al. Clinical and neuropathological assessment of severity in Huntington’s disease. Neurology 1988;38:341-7
35. Zalneraitis EL, Landis DMD, Richardson EP Jr, Selkoe DJ. A comparison of astrocytic structure in cerebral cortex and striatum in Huntington’s disease. Neurology (Abstract) 1981;31(4, pt 2):151
36. de la Monte SM, Ulcickas M, Hedley-Whyte ET. Disproportionate loss of cerebral white matter in patients with Alzheimer’s Disease (AD) (Abstract). Lab Invest 1987;56(1):18A
37. de la Monte SM. Disproportionate atrophy of cerebral white matter in chronic alcoholics. Arch Neurol 1988 (in press)
38. Caine ED, Shoulson I. Psychiatric syndromes in Huntington’s disease. Am J Psychiat 1983;140: 728-33